Pronóstico del mercado de bioprocesamiento en Europa hasta 2031: análisis regional por producto (instrumentos, consumibles y accesorios), escala de operación (operaciones comerciales y operaciones clínicas), proceso (bioprocesos posteriores y anteriores), aplicación (anticuerpos monoclonales, vacunas, proteínas recombinantes, terapia celular y génica, entre otros) y usuario final (empresas biofarmacéuticas, organizaciones de fabricación por contrato y otras)
La creciente industria biofarmacéutica impulsa el mercado de bioprocesamiento en Europa
En la industria biofarmacéutica, siempre se demandan bioprocesos mejorados para abordar nuevos requisitos regulatorios, requisitos de control de calidad y problemas de producción en productos biológicos, titulación de cultivos celulares y producción de biosimilares. En los últimos años, la industria biofarmacéutica ha estado creciendo a un ritmo sin precedentes. Las empresas biofarmacéuticas están gastando enormes sumas en I+D para introducir nuevas moléculas con mayor potencia médica y comercial para diversas aplicaciones terapéuticas. La aceptación del bioprocesamiento está aumentando gradualmente debido a su amplia aplicación en la investigación, el desarrollo y la fabricación de productos biológicos y biosimilares. Las grandes compañías farmacéuticas y las organizaciones de investigación por contrato están creando nuevos medicamentos y formas de terapia para tratar una amplia gama de indicaciones. Además, una fuerte demanda de productos biológicos y biosimilares para tratar enfermedades crónicas está, a su vez, impulsando el crecimiento de la industria biofarmacéutica. La industria biofarmacéutica es uno de los contribuyentes más importantes a la economía. Factores como el aumento de la aprobación de productos biológicos, el crecimiento de la cartera de biosimilares, el aumento de la inversión en actividades de investigación y el mayor enfoque en el desarrollo de productos biológicos asequibles están facilitando el crecimiento de la industria biofarmacéutica.
Aparte de esto, el aumento de las aprobaciones en terapias génicas y celulares está favoreciendo el crecimiento del mercado de bioprocesamiento. Las terapias génicas aprobadas son Glybera (para tratar la deficiencia de lipoproteína lipasa) y Strimvelis (para tratar la inmunodeficiencia combinada grave de ADA). Por lo tanto, los factores mencionados anteriormente están aumentando la demanda de producción a gran escala de varios productos terapéuticos, lo que facilita el crecimiento del mercado de bioprocesamiento.
Resumen del mercado de bioprocesamiento en Europa
Los biosimilares introducen competencia y aumentan la asequibilidad de los productos biológicos, lo que en última instancia ofrece ahorros y servicios de valor agregado para respaldar la atención al paciente y la industria de la salud. Los profesionales de la salud pueden tratar a más pacientes con productos biológicos de alta calidad a un costo reducido. Debido al enorme potencial de ahorro de costos, el Ministerio de Salud alemán introdujo una nueva ley para aumentar la adopción de biosimilares. Además, un número creciente de asociaciones entre actores internacionales impulsa el crecimiento del mercado en el país. Por ejemplo, en noviembre de 2020, Hitachi Chemical Advanced Therapeutics Solutions, LLC y apceth Biopharma GmbH ampliaron su relación con Bluebird Bio para celebrar acuerdos de servicios de desarrollo y fabricación a largo plazo para el suministro clínico y comercial de múltiples terapias, así como para ampliar la capacidad de fabricación de productos farmacéuticos comerciales en Europa para ZYNTEGLO, una terapia génica de una sola vez para la β-talasemia dependiente de transfusión (TDT). Además, el sector de la biotecnología en Alemania muestra un enorme crecimiento debido a la presencia de numerosas empresas de biotecnología, laboratorios de investigación de alta tecnología y una financiación masiva para investigación y desarrollo. El crecimiento de la investigación y el desarrollo en productos biofarmacéuticos y biológicos está impulsado principalmente por la adopción de diversas estrategias orgánicas por parte de las empresas de la industria de la salud. Por ejemplo, en junio de 2021, Rentschler Biopharma amplió su capacidad de producción con un biorreactor de 2.000 litros para abordar la creciente demanda de anticuerpos complejos, una clase de medicamentos biofarmacéuticos con un potencial alto y continuo. Asimismo, en agosto de 2023, Sartorius, uno de los principales proveedores de la industria biofarmacéutica, colaboró con el líder mundial en tecnología y software Emerson para integrar la familia de biorreactores Biostat STR Generation 3 de Sartorius con el sistema de control distribuido (DCS) DeltaVTM de Emerson. Por lo tanto, el sector biofarmacéutico en el país está creciendo debido al aumento del gasto en I+D por parte de las empresas biofarmacéuticas. Por lo tanto, los esfuerzos de investigación colaborativa de las empresas biofarmacéuticas y biotecnológicas del país influyen en el mercado.
Ingresos y pronóstico del mercado de bioprocesamiento en Europa hasta 2031 (millones de dólares estadounidenses)
Segmentación del mercado de bioprocesamiento en Europa
El mercado de bioprocesamiento en Europa se clasifica en producto, escala de operación, proceso, aplicación, usuario final y país.
Según el producto, el mercado de bioprocesamiento en Europa se bifurca en instrumentos y consumibles y accesorios. El segmento de instrumentos tuvo una mayor participación de mercado en 2023. Además, el segmento de instrumentos está subsegmentado en dispositivos de filtración, biorreactores, sistemas de cromatografía, centrífugas, dispositivos de secado y otros. Además, el subsegmento de biorreactores se clasifica en escala piloto, escala completa y escala de laboratorio. Además, el subsegmento de sistemas de cromatografía está segmentado en cromatografía líquida, cromatografía de gases y otros. Además, el segmento de consumibles y accesorios está subsegmentado en reactivos, medios de cultivo celular, resinas de cromatografía y otros.
En términos de escala de operación, el mercado de bioprocesamiento de Europa se bifurca en operaciones comerciales y operaciones clínicas. El segmento de operaciones comerciales tuvo una mayor participación de mercado en 2023.
Por proceso, el mercado de bioprocesamiento de Europa se bifurca en bioproceso descendente y bioproceso ascendente. El segmento de bioproceso descendente tuvo una mayor participación de mercado en 2023.
Según la aplicación, el mercado de bioprocesamiento de Europa se clasifica en anticuerpos monoclonales, vacunas, proteínas recombinantes, terapia celular y génica, y otros. El segmento de anticuerpos monoclonales tuvo la mayor participación de mercado en 2023.
En términos de usuario final, el mercado de bioprocesamiento de Europa se clasifica en empresas biofarmacéuticas, organizaciones de fabricación por contrato y otros. El segmento de empresas biofarmacéuticas tuvo la mayor participación de mercado en 2023.
Por país, el mercado de bioprocesamiento de Europa está segmentado en Alemania, Francia, Italia, Reino Unido, España y el resto de Europa. Alemania dominó la participación de mercado de bioprocesamiento de Europa en 2023.
Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Repligen Corp, Entegris Inc, Agilent Technologies Inc y Cytiva US LLC. son algunas de las empresas líderes que operan en el mercado de bioprocesamiento de Europa.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Bioprocessing Market Landscape
4.1 Ecosystem Analysis
4.1.1 List of Vendors in the Value Chain
5. Europe Bioprocessing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Biopharmaceutical Industry
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
5.3 Market Opportunities
5.3.1 Proliferating Demand for Personalized Medicine
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact of Drivers and Restraints:
6. Bioprocessing Market - Europe Analysis
6.1 Europe Bioprocessing Market Overview
6.2 Bioprocessing Market Revenue (US$ Million), 2021-2031
7. Europe Bioprocessing Market Analysis - by Product
7.1 Overview
7.2 Instruments
7.2.1 Overview
7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
7.3 Consumables & Accessories
7.3.1 Overview
7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
8. Europe Bioprocessing Market Analysis - by Scale of Operation
8.1 Overview
8.2 Commercial Operations
8.2.1 Overview
8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Operations
8.3.1 Overview
8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9. Europe Bioprocessing Market Analysis - by Process
9.1 Overview
9.2 Downstream Bioprocess
9.2.1 Overview
9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Upstream Bioprocess
9.3.1 Overview
9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10. Europe Bioprocessing Market Analysis - by Application
10.1 Overview
10.2 Monoclonal Antibodies
10.2.1 Overview
10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Vaccines
10.3.1 Overview
10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Recombinant Protein
10.4.1 Overview
10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Cell & Gene Therapy
10.5.1 Overview
10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11. Europe Bioprocessing Market Analysis - by End User
11.1 Overview
11.2 Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Contract Manufacturing Organization
11.3.1 Overview
11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12. Europe Bioprocessing Market - Country Analysis
12.1 Europe
12.1.1 Europe: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
12.1.1.1 Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.1.1 Overview
12.1.1.2 Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.2.1 Germany: Bioprocessing Market Breakdown, by Product
12.1.1.2.1.1 Germany: Bioprocessing Market Breakdown, by Instruments
12.1.1.2.1.1.1 Germany: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.2.1.1.2 Germany: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.2.1.2 Germany: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.2.2 Germany: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.2.3 Germany: Bioprocessing Market Breakdown, by Process
12.1.1.2.4 Germany: Bioprocessing Market Breakdown, by Application
12.1.1.2.5 Germany: Bioprocessing Market Breakdown, by End User
12.1.1.3 United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 Overview
12.1.1.4 United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.4.1 United Kingdom: Bioprocessing Market Breakdown, by Product
12.1.1.4.1.1 United Kingdom: Bioprocessing Market Breakdown, by Instruments
12.1.1.4.1.1.1 United Kingdom: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.4.1.1.2 United Kingdom: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.4.1.2 United Kingdom: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.4.2 United Kingdom: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.4.3 United Kingdom: Bioprocessing Market Breakdown, by Process
12.1.1.4.4 United Kingdom: Bioprocessing Market Breakdown, by Application
12.1.1.4.5 United Kingdom: Bioprocessing Market Breakdown, by End User
12.1.1.5 France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.5.1 Overview
12.1.1.6 France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.6.1 France: Bioprocessing Market Breakdown, by Product
12.1.1.6.1.1 France: Bioprocessing Market Breakdown, by Instruments
12.1.1.6.1.1.1 France: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.6.1.1.2 France: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.6.1.2 France: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.6.2 France: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.6.3 France: Bioprocessing Market Breakdown, by Process
12.1.1.6.4 France: Bioprocessing Market Breakdown, by Application
12.1.1.6.5 France: Bioprocessing Market Breakdown, by End User
12.1.1.7 Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.7.1 Overview
12.1.1.8 Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.8.1 Italy: Bioprocessing Market Breakdown, by Product
12.1.1.8.1.1 Italy: Bioprocessing Market Breakdown, by Instruments
12.1.1.8.1.1.1 Italy: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.8.2 Italy: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.8.2.1 Italy: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.8.3 Italy: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.8.4 Italy: Bioprocessing Market Breakdown, by Process
12.1.1.8.5 Italy: Bioprocessing Market Breakdown, by Application
12.1.1.8.6 Italy: Bioprocessing Market Breakdown, by End User
12.1.1.9 Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.9.1 Overview
12.1.1.10 Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.10.1 Spain: Bioprocessing Market Breakdown, by Product
12.1.1.10.1.1 Spain: Bioprocessing Market Breakdown, by Instruments
12.1.1.10.1.1.1 Spain: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.10.1.1.2 Spain: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.10.1.2 Spain: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.10.2 Spain: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.10.3 Spain: Bioprocessing Market Breakdown, by Process
12.1.1.10.4 Spain: Bioprocessing Market Breakdown, by Application
12.1.1.10.5 Spain: Bioprocessing Market Breakdown, by End User
12.1.1.11 Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.11.1 Overview
12.1.1.12 Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.12.1 Rest of Europe: Bioprocessing Market Breakdown, by Product
12.1.1.12.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Instruments
12.1.1.12.1.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.12.1.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.12.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.12.2 Rest of Europe: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.12.3 Rest of Europe: Bioprocessing Market Breakdown, by Process
12.1.1.12.4 Rest of Europe: Bioprocessing Market Breakdown, by Application
12.1.1.12.5 Rest of Europe: Bioprocessing Market Breakdown, by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Bioprocessing Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Getinge AB
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sartorius AG
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Corning Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bio-Rad Laboratories Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck KGaA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 3M Co
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Eppendorf SE
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Repligen Corp
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Entegris Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Agilent Technologies Inc
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Cytiva US LLC
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
?
List of Tables
Table 1. Europe Bioprocessing Market Segmentation
Table 2. List of Vendors
Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
Table 7. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 8. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 9. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 10. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 11. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 12. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 13. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 14. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 15. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 16. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 17. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 18. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 19. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 20. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 21. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 22. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 23. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 24. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 25. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 26. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 27. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 28. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 29. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 30. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 31. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 32. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 33. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 34. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 35. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 36. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 37. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 38. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 39. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 40. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 41. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 42. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 43. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 44. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 45. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 46. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 47. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 48. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 49. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 50. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 51. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 52. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 53. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 54. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 55. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 56. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 57. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 58. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 59. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 60. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 61. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 62. Recent Organic Growth Strategies in the Bioprocessing Market
Table 63. Glossary of Terms, Bioprocessing Market
?
List of Figures
Figure 1. Europe Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Europe: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. Europe: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 31. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 32. Growth Strategies in the Bioprocessing Market
- Getinge AB
- Thermo Fisher Scientific Inc
- Sartorius AG
- Corning Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- 3M Co
- Eppendorf SE
- Repligen Corp
- Entegris Inc
- Agilent Technologies Inc
- Cytiva US LLC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe bioprocessing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe bioprocessing market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.